Effect of vascular endothelial growth factor and epidermal growth factor on iatrogenic apoptosis in human endothelial cells

Biochemical Pharmacology

Volumn 67, Issue 2, 2004, Pages 277-284

  Vinci, Maria Cristina ^a   Visentin, Barbara ^a   Cusinato, Federico ^a   Nardelli, Giovanni Battista ^a   Trevisi, Lucia ^a   Luciani, Sisto ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Apoptosis; EGF; ERKs; PI 3 kinase; Staurosporine; VEGF

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; CASPASE 3; EPIDERMAL GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN MCL 1; STAUROSPORINE; VASCULOTROPIN; WORTMANNIN;

APOPTOSIS; ARTICLE; CELL PROTECTION; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; NICK END LABELING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

EID: 1642579540     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2003.09.007     Document Type: Article

References (42)

1. Lüscher TF, Barton M. Biology of the endothelium. Clin Cardiol 1997; 20 (Suppl II): II-3-10.
2. Mallat Z., Tedgui A. Apoptosis in the vasculature: mechanisms and functional importance. Br. J. Pharmacol. 130:2000;947-962.
3. Mallat Z., Tedgui A. Current perspective on the role of apoptosis in atherothrombotic disease. Circ. Res. 88:2001;998-1003.
4. Zachary I. Signaling mechanisms mediating vascular protective actions of vascular endothelial growth factor. Am. J. Physiol. Cell Physiol. 280:2001;C1375-C1386.
5. Matsumoto T, Claesson-Welsh L. VEGF receptor signal transduction. Sci STKE 2001112:RE21.
6. Tauchi H., Kawaishi K., Kimura A., Satow Y. Expression of the vascular endothelial growth factor (VEGF) receptor gene, KDR, in hematopoietic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionizing radiation. Cancer Res. 55:1995;5687-5692.
7. Spyridopoulos I., Brogi E., Kearney M., Sullivan A.B., Cetrulo C., Isner J.M., Losordo D.W. Vascular endothelial growth factor inhibits endothelial cell apoptosis induced by tumor necrosis factor-α: balance between growth and death signals. J. Mol. Cell Cardiol. 29:1997;1321-1330.
8. Gerber H.P., McMurtrey A., Kowalski J., Yan M., Key B.A., Dixit V., Ferrara N. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. J. Biol. Chem. 273:1998;30336-30343.
9. Kuzuya M., Ramos M.A., Kanda S., Koike T., Asai T., Maeda K., Shitara K., Shibuya M., Iguchi A. VEGF protects against oxidized LDL toxicity to endothelial cells by an intracellular glutathione-dependent mechanism through the KDR receptor. Arterioscler. Thromb. Vasc. Biol. 21:2001;765-774.
10. Gerber H.P., Dixit V., Ferrara N. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1. J. Biol. Chem. 273:1998;13313-13316.
11. Katoh O., Takahashi T., Oguri T., Kuramoto K., Mihara K., Kobayashi M., Hirata S., Watanabe H. Vascular endothelial growth factor inhibits apoptotic death in hematopoietic cells after exposure to chemotherapeutic drugs by inducing MCL1 acting as an antiapoptotic factor. Cancer Res. 58:1998;5565-5569.
12. Lorenzo E., Ruiz-Ruiz C., Quesada A.J., Hernandez G., Rodriguez A., Lopes-Rivas A., Redondo J.M. Doxorubicin induces apoptosis and CD95 gene expression in human primary endothelial cells through a p53-dependent mechanism. J. Biol. Chem. 277:2002;10883-10892.
13. Wang Z., Jiang C., Ganther H., Lu J. Antimitogenic and proapoptotic activities of methylseleninic acid in vascular endothelial cells and associated effects on PI3K-AKT, ERK, JNK and p38 MAPK signaling. Cancer Res. 61:2001;7171-7178.
14. Gesher A. Staurosporine analogues-pharmacological toys or useful antitumour agents? Crit. Rev. Oncol./Hematol. 34:2000;127-135.
15. Leu C.M., Chang C., Hu C. Epidermal growth factor (EGF) suppresses staurosporine-induced apoptosis by inducing mcl-1 via the mitogen-activated protein kinase pathway. Oncogene. 19:2000;1665-1675.
16. Jaffe E.A., Hoyer L.W., Nachman R.L. Synthesis of von Willebrand factor by cultured human endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 71:1974;1906-1909.
17. Bensadoun A., Weinstein D. Assay of proteins in the presence of interfering materials. Anal. Biochem. 70:1976;241-250.
18. Bombeli T., Karsan A., Tait J.F., Harlan J.M. Apoptotic vascular endothelial cells become procoagulant. Blood. 7:1997;2429-2442.
19. Ackermann E.J., Taylor J.K., Narayana R., Bennett C. The role of antiapoptotic Bcl-2 family members in endothelial apoptosis elucidated with antisense oligonucleotides. J. Biol. Chem. 274:1998;11245-11252.
20. Kitada S., Zapata J.M., Andreeff M., Reed J.C. Protein kinase flavopiridol and 7-hydroxy-staurosporine down-regulate antiapoptosis proteins in B-cell chronic lymphocytic leukemia. Blood. 96:2000;393-397.
21. Borner C. The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Mol. Immunol. 39:2003;615-647.
22. Townsend K.J., Zhou P., Qian L., Bieszczad C.K., Lowrey H., Yen A., Craig R.W. Regulation of Mcl-1 through a serum response factor/Elk-1-mediated mechanism links expression of a viability-promoting member of the BCL2 family to the induction of hematopoietic cell differentiation. J. Biol. Chem. 15:1999;1801-1813.
23. Baselga J. Why epidermal growth factor receptor? The rationale for cancer therapy. The Oncologist. 7(Suppl. 4):2002;2-8.
24. Liu J., Tian Z., Gao B., Kunos G. Dose-dependent activation of antiapoptotic and proapoptotic pathways by ethanol treatment in human vascular endothelial cells: differential involvement of adenosin. J. Biol. Chem. 277:2002;20927-20933.
25. Alessi D.R., Cuenda A., Cohen P., Dudley D.T., Saltiel A.R. PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270:1995;27489-27494.
26. Favata M.F., Horiuchi K.Y., Manos E.J., Daulerio A.J., Stradley D.A., Feeser W.S., Van Dyk D.E., Pitts W.J., Earl R.A., Hobbs F., Copeland R.A., Magolda R.L., Scherle P.A., Trzaskos J.M. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273:1998;18623-18632.
27. Parillo J.E., Fauci A.S. Mechanisms of glucocorticoid action on immune processes. Ann. Rev. Pharmacol. Toxicol. 19:1979;179.
28. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J., Holash J. Vascular-specific growth factors and blood vessel formation. Nature. 407:2000;242-248.
29. Fiorucci S., Mencarelli A., Manucci R., Distrutti E., Morelli A., del Soldato P. NCX-4016, a nitric oxide-releasing aspirin, protects endothelial cells against apoptosis by modulating mitochondrial function. FASEB J. 16:2002;1645-1647.
30. Stepczynska A., Lauber K., Engels I.H., Janssen O., Kabelitz D., Wesselborg S., Schulze-Osthoff K. Staurosporine and conventional anticancer drugs induce overlapping, yet distinct pathways of apoptosis and caspase activation. Oncogene. 20:2001;1193-1202.
31. Belmokhtar C.A., Hillion J., Ségal-Bendirdjian E. Staurosporine induces apoptosis through both caspase-dependent and caspase-independent mechanisms. Oncogene. 20:2001;3354-3362.
32. Lan L., Wong N.S. Phosphatidylinositol 3-kinase and protein kinase C are required for the inhibition of caspase activity by epidermal growth factor. FEBS Lett. 444:1999;90-96.
33. Kennedy SG, Wagner AJ, Conzen SD, Jordan J, Bellacosa A, Tsichlis PN, Hay N. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev 1997;15(11):701-13.
34. Goswami R., Dawson S.A., Dawson G. Cyclic AMP protects against staurosporine and wortmannin-induced apoptosis and opioid-enhanced apoptosis in both embryonic and immortalized (F-11kappa7) neurons. J. Neurochem. 70:1998;1376-1382.
35. Wu L.W., Mayo L.D., Dunbar J.D., Kessler K.M., Baerwald M.R., Jaffe E.A., Wang D., Warren R.S., Donner D.B. Utilization of distinct signaling pathway by receptors for vascular endothelial cell growth factor and other mitogen in the induction of endothelial cell proliferation. J. Biol. Chem. 275:2000;5096-5103.
36. Reed J.C. Molecular biology of chronic lymphocytic leukaemia: implications for therapy. Semin. Hematol. 35:1998;3-13.
37. Reynolds J.E., Li J., Craig R.W., Eastman A. BCL-2 and MCL-1 expression in Chinese hamster ovary cells inhibits intracellular acidification and apoptosis induced by staurosporine. Exp. Cell Res. 225:1996;430-436.
38. Araki T., Hayashi M., Watanabe N., Kanuka H., Yoshino J., Miura M., Saruta T. Down-regulation of Mcl-1 by inhibition of the PI3-K/Akt pathway is required for cell shrinkage-dependent cell death. Biochem. Biophys. Res. Commun. 290:2002;1275-1281.
39. Kuo M.L., Chuang S.E., Lin M.T., Yang S.Y. The involvement of PI 3-K/Akt-dependent up-regulation of Mcl-1 in the prevention of apoptosis of Hep3B cells by interleukin-6. Oncogene. 20:2001;677-685.
40. Wang J.M., Chao J.R., Chen W., Kuo M.L., Yen J.J.-Y., Yang-Yen H.F. The antiapoptotic gene mcl-1 is up-regulated by the phosphatidylinositol 3-kinase/Akt signaling pathway through a transcription factor complex containing CREB. Mol. Cell Biol. 19:1999;6195-6206.
41. Boucher M.J., Morisset J., Vachon P.H., Reed J.C., Laine J., Rivard N. MEK/ERK signalling pathway regulates the expression of Bcl-2, Bcl-X(L), and Mcl-1 and promotes survival of human pancreatic cancer cells. J. Cell Biochem. 79:2000;355-369.
42. Huang H.M., Huang C.J., Yen J.J. Mcl-1 is a common target of stem cell factor and interleukin-5 for apoptosis prevention activity via MEK/MAPK and PI-3K/Akt pathways. Blood. 96:2000;1764-1771.